5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione
Phenobarbital is a barbiturate with sedative and anticonvulsant effects. It enhances the action of the neurotransmitter GABA at the GABA-A receptor, leading to inhibition of neuronal activity. The substance is primarily used for the treatment of epilepsy and has a moderate risk for dependence and adverse effects. Due to its mechanism of action, phenobarbital can lead to severe central nervous system depression in cases of overdose.
Class
Barbiturate
Pharmacological context
Mechanism
Phenobarbital wirkt als ein langwirksames Barbiturat, das die...
Short read on known pharmacology
Interactions
No curated pairs visible
Curated visible combinations
Risk theme
Interpret risks carefully
Condensed from structured notes
Receptor Targets
Mechanism of Action
Designations
IUPAC: 5-ethyl-5-phenyl-barbituric acid
Legal Status
Legal status not verified by official sources. Please check current legislation independently.
Information without guarantee. Not legal advice.
Receptor Profile
Der NMDA-Rezeptor ist ein ionotroper Glutamatrezeptor, der eine zentrale Rolle bei synaptischer Plastizität, Lernen und Gedächtnisbildung spielt. Er benötigt sowohl Glutamat als auch Glycin als Co-Agonisten zur Aktivierung.
Der AMPA-Rezeptor ist ein ionotroper Glutamatrezeptor, der die schnelle exzitatorische synaptische Übertragung im ZNS vermittelt. Er arbeitet eng mit NMDA-Rezeptoren bei der synaptischen Plastizität zusammen.
Synapedia Evidence
Effects & Pharmacology is partially translated. Some details are still being expanded.
Phenobarbital wirkt als ein langwirksames Barbiturat, das die GABA-A-Rezeptoren im zentralen Nervensystem aktiviert und dadurch die neuronale Erregbarkeit verringert.
Known Effects
Individual effects may vary significantly. These are pharmacologically documented effects.
Reported range 60–120 mg
Total duration 6–12 hours
Oral
| Tier | Dosage |
|---|---|
| Light | 30–60 mg |
| Reported | 60–120 mg |
| Strong | 120–300 mg |
Oral
Onset
30–60 minutes
Peak
2–4 hours
Total duration
6–12 hours
Avoid uncertain dosage claims and do not infer numbers when data is unclear.
Dose sensitivity varies greatly between individuals. Body weight, tolerance, route of administration, combinations, and pre-existing conditions significantly affect outcomes. These figures are not dosing recommendations — they describe reported ranges, not safe amounts.
Risks
Summary
Kann zu Abhängigkeit führen, Überdosierung ist möglich.
Safer Use
The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
Interaction details from the knowledge layer are still being translated.
Interaction data is based on known mechanisms. Unknown or rare interactions are possible and may be life-threatening.
Based on substance class, receptors, mechanisms, and effect profile.
This information is for scientific and harm-reduction purposes only. It does not constitute medical advice.
Share a report, observation, or question about this substance. Entries are reviewed before publication and marked as unverified community signals.
These entries are submitted by users and are not verified. They may contain subjective experiences, observations, source leads, or corrections. They do not replace scientific data and are not consumption advice.
The signal hub collects approved risk signals, experience reports and source leads by relevance.